The relationship between osteoporosis and bone metabolism disorders and diabetes is increasingly recognized, as poor glycemic control negatively affects bone density and fracture risk. Insulin plays a role in bone formation, and disruptions in glucose metabolism contribute to skeletal fragility. Diabetic patients, particularly those with long-standing disease, face an increased likelihood of osteoporosis and delayed bone healing. Advances in bone research highlight the role of vitamin D, calcium metabolism, and novel anti-osteoporotic agents in mitigating these risks. Emerging therapies, including anabolic bone treatments and personalized nutrition strategies, are being explored to enhance skeletal health. Addressing bone metabolism disorders in diabetic individuals is crucial for reducing long-term complications.
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, IUHS School of Medicine, Saint Kitts and Nevis
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Clinical applications of monitoring unmethylated insulin cfDNA associated with beta-cell death for diabetes and metabolic diseases
Clifford Morris, Kihealth, United States
Title : Diabetes and migration: Impact of internal displacement on the prevalence and management of diabetes in Les Cayes, South Haiti (2022-2024)
Berger Saintius, Field Epidemiology Training Program (FETP), Haiti
Title : Correlation between food insecurity and diabetes in the commune of Les Cayes (2021-2024)
Djeamsly Salomon, Field Epidemiology Training Program (FETP), Haiti